Identification of citrullinated cellular fibronectin in synovial fluid from patients with rheumatoid arthritis

Modern Rheumatology

Volumn 24, Issue 5, 2014, Pages 766-769

  Kimura, Eri ^a   Kanzaki, Takeyuki ^b   Tahara, Koichiro ^a   Hayashi, Haeru ^a   Hashimoto, Shiori ^c   Suzuki, Akari ^d   Yamada, Ryo ^e   Yamamoto, Kazuhiko ^f   Sawada, Tetsuji ^a  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b Yamanashi Prefectural Central Hospital   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cellular fibronectin; Citrullinated antigen; Rheumatoid arthritis; Synovial fluid

Indexed keywords

FIBRONECTIN; STROMELYSIN; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; WESTERN BLOTTING; CHEMISTRY; IMMUNOLOGY; METABOLISM;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FIBRONECTINS; HUMANS; OSTEOARTHRITIS; PEPTIDES, CYCLIC; SYNOVIAL FLUID;

EID: 84906326401     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2013.879413     Document Type: Article

References (20)

1. Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet. 2003;34(4):395-402.
2. Suwannalai P, Trouw L.A, Toes R.E, Huizinga T W. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod Rheumatol. 2012; 22(1): 15-20.
3. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G. The major synovial targets of the rheumatoid arthritis-specifi c antifi laggrin autoantibodies are deiminated forms of the alpha-And beta-chains of fi brin. J Immunol. 2001;166(6):4177-84.
4. Tilleman K, Van Steendam K, Cantaert T, De Keyser F, Elewaut D, Deforce D. Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in infl ammatory arthritides. Rheumatology (Oxford). 2008; 47(5): 597-604.
5. Chang X, Yamada R, Suzuki A, Kochi Y, Sawada T, Yamamoto K. Citrullination of fi bronectin in rheumatoid arthritis synovial tissue. Rheumatology (Oxford). 2005; 44(11): 1374-82.
6. Takizawa Y, Suzuki A, Sawada T, Ohsak AM, Inoue T, Yamada R, Yamamoto K. Citrullinated fi brinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fl uids. Ann Rheum Dis. 2006;65(8):1013-20.
7. Tabushi Y, Nakanishi T, Takeuchi T, Nakajim AM, Ueda K, Kotani T, et al. Detection of citrullinated proteins in synovial fl uids derived from patients with rheumatoid arthritis by proteomics-based analysis. Ann Clin Biochem. 2008;45(Pt 4):413-7.
8. Van Beers J.J, Willemze A, Stammen-Vogelzangs J, Drijfhout J.W, Toes RE, Pruijn GJ. Anti-citrullinated fi bronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles. Arthritis Res Ther. 2012; 14(1): R35.
9. Van Beers JJ, Schwarte CM, Stammen-Vogelzangs J, Oosterink E, Božic B, Pruijn GJ. The rheumatoid arthritis synovial fl uid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear diff erentiation antigen, and beta-Actin. Arthritis Rheum. 2013;65(1):69-80.
10. Skriner K, Adolph K, Jungblut PR, Burmester GR. Association of citrullinated proteins with synovial exosomes. Arthritis Rheum. 2006;54(12):3809-14.
11. Kinloch A, Lundberg K, Wait R, Wegner N, Lim N.H, Zendman A.J, et al. Synovial fl uid is a site of citrullination of autoantigens in infl ammatory arthritis. Arthritis Rheum. 2008;58(8):2287-95.
12. To WS, Midwood KS. Plasma and cellular fi bronectin: Distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair. 2011;4:21.
13. Peters JH, Maunder RJ, Woolf AD, Cochrane CG, Ginsberg MH. Elevated plasma levels of ED1 - ( " cellular " ) fi bronectin in patients with vascular injury. J Lab Clin Med. 1989;113(5):586-97.
14. Walle TK, Vartio T, Helve T, Virtanen I, Kurki P. Cellular fi bronectin in rheumatoid synovium and synovial fl uid: A possible factor contributing to lymphocytic infi ltration. Scand J Immunol. 1990;31(4):535-40.
15. Shiozawa K, Hino K, Shiozawa S. Alternatively spliced EDAcontaining fi bronectin in synovial fl uid as a predictor of rheumatoid joint destruction. Rheumatology (Oxford). 2001; 40(7): 739-42.
16. Yan X, Yin L, Wang Y, Zhao Y, Chang X. The low binding affi nity of ADAMTS4 for citrullinated fi bronectin may contribute to the destruction of joint cartilage in rheumatoid arthritis. Clin Exp Rheumatol. 2012; 31(2): 201-206.
17. Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(7):969-75.
18. Fan L, Wang Q, Liu R, Zong M, He D, Zhang H, et al. Citrullinated fi bronectin inhibits apoptosis and promotes the secretion of proinfl ammatory cytokines in fi broblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther. 2012;14(6):R266.
19. Shelef M.A, Bennin D.A, Mosher D.F, Huttenlocher A. Citrullination of fi bronectin modulates synovial fi broblast behavior. Arthritis Res Ther. 2012;14(6):R240.
20. Van Venrooij W.J, Pruijn G J. A n important step towards completing the rheumatoid arthritis cycle. Arthritis Res Ther. 2008; 10(5): 117.